Abstract
Moving The Needle On Heart Failure Prevention: The Use Of A Noninvasive Sensor For The Early Detection Of Volume Overload In Stage A Heart Failure Patients
Journal of cardiac failure, Vol.32(1), p.290
01/2026
DOI: 10.1016/j.cardfail.2025.11.295
Abstract
Background
Heart failure carries a significant morbidity and mortality burden. Recent guidelines have emphasized early detection and treatment for patients with Stage A (risk factors but no symptoms) and Stage B (asymptomatic cardiac structural changes) HF to slow or prevent the development of clinical HF (Stages C & D). The VentricHealth Vivio device is an FDA-approved device that has been shown to accurately and quickly estimate LVEDP non-invasively using an ECG patch and an arm cuff in an office setting.
Goal
To non-invasively assess the prevalence of hemodynamic congestion in an ambulatory population of Stage A HF patients using the VentricHealth Vivio device.
Methods
During a pilot period between September 17, 2025 - March 1, 2025. Over 10,000 patients age 65+ presenting to affiliated practices in Akron, OH for routine PCP appointments were pre-screened for Stage A HF. Patients qualified for Stage A HF if they were free of HF symptoms/diagnosis and had DM2 or CKD ≥ 3. 1,179 patients were identified and underwent testing with the aforementioned noninvasive device. 47% of patients (n=555; 53% female, 47% male)) tested positive with an estimated LVEDP ≥ 18 and were referred for further testing with BNP and echocardiography. Additionally, on follow-up questioning, 71% of the previously “asymptomatic” patients who tested positive for an elevated LVEDP reported symptoms concerning for HF on KCCQ-12 testing and thus were reclassified as Stage C HF patients (symptomatic with elevated filling pressures) and were re-evaluated for appropriate therapy. In a follow-up chart review of a 100 randomly -selected patients with positive testing, 85% were found to have clinically significant findings on echocardiography (LVH, LAE, LV dysfunction, aortic stenosis).
Conclusion
Asymptomatic (and/or under-recognized) hemodynamic congestion was highly prevalent in an elderly population with Stage A HF presenting for routine PCP visits. Screening programs using non-invasive technology to detect subclinical congestion can lead to earlier detection and treatment of patients at risk for developing clinical HF.
Details
- Title: Subtitle
- Moving The Needle On Heart Failure Prevention: The Use Of A Noninvasive Sensor For The Early Detection Of Volume Overload In Stage A Heart Failure Patients
- Creators
- Victoria DigennaroJay ThakerCamille JohnsonPatrick GogginKellyAnn Light-McGroaryDan R. Bensimhon
- Resource Type
- Abstract
- Publication Details
- Journal of cardiac failure, Vol.32(1), p.290
- DOI
- 10.1016/j.cardfail.2025.11.295
- ISSN
- 1071-9164
- Publisher
- Elsevier
- Language
- English
- Date published
- 01/2026
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985123701802771
Metrics
1 Record Views